aod9604 slu pp 332 bloend AOD-9604 Dosage Guide: Complete Protocol for Safe Administration SLU-PP-332 Capsules

However, large obesity trials did not show clinically meaningful weight loss, and regulators have raised concerns about immunogenicity and safety data gaps, which is why Better Med Spa restricts its use to clearly informed, highly selected clients

In conclusion, multiple clinical studies have suggested that the peptide may significantly induce lipolysis and possibly prevent lipogenesis by mimicking natural hGH

Weight regulation : In mouse studies, systemic administration produced a progressive reduction in body weight and up to a ~35% decrease in white adipose tissue mass

For the 3.2 mg dose used here, add 2.5 mL to an 80 mg vial

But failed to achieve FDA approval, leaving it in research-grade limbo

These figures are provided for research reference only and do not constitute dosing recommendations